Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Biological monitoring of IFN-β therapy in Multiple Sclerosis.
The profile of patients followed at the Neuroimmunology Clinic at UNIFESP: 20 years analysis.
Mitochondrial DNA sequence variation in multiple sclerosis.
Robot Therapy Tipping Point: Caveats for Post hoc Speculation.
Loci associated with N-glycosylation of human immunoglobulin g show pleiotropy with autoimmune diseases and haematological cancers.
Successful trabeculotomy in a patient with corticosteroid-induced glaucoma with anti-aquaporin 4 antibody-positive neuromyelitis optica: a case report.
Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity.
Chronic cerebrospinal venous insufficiency is not associated with multiple sclerosis and its severity: a blind-verified study.
[Indexes of integrative activity of motor system in norm and at neuromotor pathology].
Evaluation of brainstem involvement in multiple sclerosis.
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review.
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
Individual Face-to-Face Cognitive Behavioural Therapy in Multiple Sclerosis: A Qualitative Study.
Three Minor Diterpenoids with Three Carbon Skeletons from Euphorbia peplus.
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation.
Human Umbilical Tissue-Derived Cells Promote Synapse Formation and Neurite Outgrowth via Thrombospondin Family Proteins.
Transplanting of Mesenchymal Stem Cells May Affect Proliferation and Function of CD4+T Cells in Experimental Autoimmune Encephalomyelitis.
Fitness and cognitive processing speed in persons with multiple sclerosis: A cross-sectional investigation.
The feasibility and short-term benefits of Blue Prescription: a novel intervention to enable physical activity for people with multiple sclerosis.
Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: Beneficial effects in experimental autoimmune encephalomyelitis.
Quantifying gait impairment using an instrumented treadmill in people with multiple sclerosis.
Multiple sclerosis: Creating a STIR-MRI sequence improves detection of spinal cord lesions.
Pages
« first
‹ previous
…
484
485
486
487
488
489
490
491
492
…
next ›
last »